Search Omvoh (mirikizumab-mrkz) injection (type in keywords)
Search Medical Information
If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Omvoh ® (mirikizumab-mrkz) injection
300 mg/15 mL, 100 mg/mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Can the use of Omvoh™ (mirikizumab-mrkz) cause a false positive on a drug screen?
Eli Lilly and Company does not comment on inquiries related to the possibility of our drug products causing false positive drug screens. False positive drug screens may depend on the sensitivity, specificity, and method of the drug screen assay.
Additional Information
The clinical laboratory that performs the drug (toxicology) screening will be able to address inquiries related to the sensitivity, specificity, and method of their particular assay against particular drug products.
Enclosed Prescribing Information
Date of Last Review: April 29, 2024
Are you satisfied with this content?